A new method to select healthier embryos for IVF
A non-invasive metabolic sensor for improving success in IVF
This study is working on a new, gentle way to help choose the best embryos during IVF, so that couples can have a better chance of a successful pregnancy without needing to transfer multiple embryos.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10894790 on NIH RePORTER |
What this research studies
This research aims to develop a non-invasive metabolic sensor that can improve the selection process of embryos during in vitro fertilization (IVF). Current methods rely on visual assessments of embryo morphology, which can be subjective and often lead to poor predictive outcomes. By utilizing advanced biosensing techniques, this project seeks to provide a more accurate and objective way to identify the healthiest embryos for transfer, potentially increasing implantation success rates and reducing the need for multiple embryo transfers. This could lead to healthier pregnancies and lower healthcare costs associated with IVF.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing IVF treatment who are seeking improved outcomes in embryo selection.
Not a fit: Patients who are not undergoing IVF or those with conditions that preclude them from IVF may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the success rates of IVF treatments and promote healthier pregnancies.
How similar studies have performed: Previous research has shown promise in using non-invasive techniques for embryo selection, indicating potential for success in this novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Abate, Adam R. — University of California, San Francisco
- Study coordinator: Abate, Adam R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.